Wednesday, 7 March 2012

Cure for Cancer found, Pharma companies ignore. No money in it for them.

The cure was discovered by scientists at the University of Alberta, in Edmonton, Canada. The cure uses a dichloroacetate, a simple drug used to treat metabolic disorders. Because it's so simple, it had no side effects and also requires no patent. Therefore, it is relatively cheap (at least in comparison to current cancer treatments) and will actually cure cancer rather than warding it off.
Also because of the fact that it can't be patented, it's hard to make a large profit off of it. Due to this, pharmaceutical companies won't touch it, because it doesn't help their pockets.This is why this discovery isn't being celebrated and making front-page headlines.
The hope is that independent companies can perfect this cure and manufacture it for the patients that desperately need it. It will be difficult going against a a major lobbyist business interest such as the pharmaceutical industry who have their hands deep in politicians' pockets, but the more the public becomes aware of this great discovery, the less can be done against it.

Monday, 1 August 2011

The National Institute for Health and Clinical Excellence (NICE) has reported that the NHS will not fund the anti-cancer drug Avastin in England and Wales.
It is used to fight late stage bowel cancer and research shows the drug can extend life an extra six weeks.

About 6,500 people per year would benefit from the drug.

Since the drug cost £21,000 for a year of treatment, the health watchdog has labelled it as too expensive.

Friday, 14 August 2009

Drug may kill cancer 'mother' cells

A major breakthrough could pave the way to wiping out cancer by targeting the deadly "mother" cells that give birth to tumours.
For the first time, scientists have identified a drug that selectively kills cancer stem cells.

Many solid tumour cancers, including breast, prostate, bowel and lung, are thought to be driven and renewed by stem cell "parents".

Like the terrifying "mother" in Ridley Scott's Alien films, cancer stem cells are elusive, highly aggressive, and hard to defeat.

And just as destroying the mother Alien prevented more of her brood threatening humanity, scientists believe tackling tumour stem cells could eradicate a cancer's source.

Cancer stem cells have always proved highly resistant to therapy agents, which is why tumours often grow back after initial treatment.

But now scientists from the Whitehead Institute for Biomedical Research in Boston, Massachusetts, have found a compound that delivers a targeted knockout blow to breast cancer stem cells.

Tested in the laboratory, the drug salinomycin was 100 times more effective at destroying the stem cells than the powerful chemotherapy agent Taxol.

Injected into mice with breast cancer, salinomycin also slowed the growth of the animal's tumours, the research, published in the journal Cell, found.

Stem cells treated with the drug were less able to seed new tumours in the mice than cells treated with Taxol. The researchers believe "dozens" of other drugs with similar properties could be discovered over the next few years.